Add BrightSurf on Google Email

Genetic causes of severe childhood brain disorders found using new computational methods

A team of researchers at Children's Hospital of Philadelphia used new computational methods to link characteristic presentations of childhood epilepsies with specific genetic variants. They analyzed clinical information and large-scale genomic data, finding associations between 11 genetic causes and specific symptoms.

SourceChildren's Hospital of Philadelphia·JournalAmerican Journal of Human Genetics·DateAug 26, 2020

New vitamin K-based drug shows promise against medication-resistant epilepsy

Researchers at the Medical University of South Carolina have developed a vitamin K-based compound that eliminates medication-resistant epileptic seizures in mice. The compound works by increasing brain cells' ability to produce energy and protects mitochondrial health, making it a promising new treatment option for those with epilepsy.

SourceMedical University of South Carolina·JournalJournal of Medicinal Chemistry·DateJul 6, 2020

Testing new treatment for epilepsy patients

Researchers have developed a new machine learning algorithm that can detect the seizure onset zone in just 10-20 minutes, eliminating the need for prolonged monitoring and reducing risks. This breakthrough could lead to a new treatment approach for epilepsy patients, particularly those with drug-resistant forms of the disease.

Better seizure control with ketogenic diet in infants with genetic epilepsy

A review of 10-year experience at Ann & Robert H. Lurie Children's Hospital of Chicago found that ketogenic diet was safe and effective in treating drug-resistant epilepsy in infants under 3 years old. Nearly half of children with genetic causes of epilepsy experienced significant seizure reduction after three months on the diet.